share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-St George Street Capital(0%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-St George Street Capital(0%)

SC 13G/A:超過5%持股股東披露文件(修正)-St George Street Capital(0%)
美股SEC公告 ·  11/06 06:02

Moomoo AI 已提取核心訊息

St George Street Capital, a charitable foundation based in England and Wales, has filed an Amendment No. 1 to the initial Statement on Schedule 13G, indicating that as of September 3, 2024, they no longer beneficially own more than 5% of Conduit Pharmaceuticals Inc.'s common stock. The amendment, dated November 6, 2024, confirms that St George Street Capital holds 0% interest in the company, with no voting or dispositive power over any shares. This filing follows the initial Schedule 13G filed on September 29, 2023. Conduit Pharmaceuticals, formerly known as Murphy Canyon Acquisition Corp., is headquartered in San Diego, California. The filing ensures compliance with SEC regulations and clarifies the ownership status of St George Street Capital with respect to Conduit Pharmaceuticals.
St George Street Capital, a charitable foundation based in England and Wales, has filed an Amendment No. 1 to the initial Statement on Schedule 13G, indicating that as of September 3, 2024, they no longer beneficially own more than 5% of Conduit Pharmaceuticals Inc.'s common stock. The amendment, dated November 6, 2024, confirms that St George Street Capital holds 0% interest in the company, with no voting or dispositive power over any shares. This filing follows the initial Schedule 13G filed on September 29, 2023. Conduit Pharmaceuticals, formerly known as Murphy Canyon Acquisition Corp., is headquartered in San Diego, California. The filing ensures compliance with SEC regulations and clarifies the ownership status of St George Street Capital with respect to Conduit Pharmaceuticals.
總部位於英格蘭和威爾士的慈善基金會St George Street Capital已經提交了修正意見書第1號,更新了關於於2024年9月3日起,他們不再持有Conduit Pharmaceuticals Inc.普通股超過5%股權的初始13G表聲明。日期爲2024年11月6日的修正意見書確認St George Street Capital對該公司沒有任何利益,也沒有任何股票的表決或處置權。這一提交是在2023年9月29日提交的初始13G表的後續。總部位於加利福尼亞州聖地亞哥的Conduit Pharmaceuticals,前身是Murphy Canyon Acquisition Corp.,提交保證符合SEC監管要求,並澄清了St George Street Capital與Conduit Pharmaceuticals之間的所有權狀態。
總部位於英格蘭和威爾士的慈善基金會St George Street Capital已經提交了修正意見書第1號,更新了關於於2024年9月3日起,他們不再持有Conduit Pharmaceuticals Inc.普通股超過5%股權的初始13G表聲明。日期爲2024年11月6日的修正意見書確認St George Street Capital對該公司沒有任何利益,也沒有任何股票的表決或處置權。這一提交是在2023年9月29日提交的初始13G表的後續。總部位於加利福尼亞州聖地亞哥的Conduit Pharmaceuticals,前身是Murphy Canyon Acquisition Corp.,提交保證符合SEC監管要求,並澄清了St George Street Capital與Conduit Pharmaceuticals之間的所有權狀態。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息